Literature DB >> 1655606

Use of conserved sequences from hepatitis C virus for the detection of viral RNA in infected sera by polymerase chain reaction.

G Inchauspe1, K Abe, S Zebedee, M Nasoff, A M Prince.   

Abstract

Three oligonucleotide primer combinations selected from the 5' noncoding, the nucleocapsid and the putative nonstructural regions of the hepatitis C virus genome were compared in a nested polymerase chain reaction assay with respect to sensitivity and specificity for the detection of viral RNA in chimpanzee-infected and human-infected sera. Sera from both the acute and the chronic phase of the infection were obtained from 13 animals inoculated with five different non-A, non-B hepatitis strains and from seven cardiac surgery patients who had non-A, non-B hepatitis develop after transfusion and who had been tested in parallel for the presence of hepatitis C virus RNA and anti-C 100-3. A total of 90% of the acute-phase and 100% of the chronic-phase sera tested positive for hepatitis C virus RNA when the 5' noncoding-derived or the nucleocapsid-derived combinations were used; only 58% and 56%, respectively, gave positive results with the putative nonstructural primers, whereas 33% and 71%, respectively, scored positive for C100-3. Thus polymerase chain reaction primers selected from either the highly conserved 5' noncoding or nucleocapsid-regions appear to provide the sensitivity and the specificity necessary to detect low levels of hepatitis C virus RNA in both chimpanzee-infected and human-infected sera.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1655606     DOI: 10.1016/0270-9139(91)90044-v

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  14 in total

Review 1.  Hepatitis C virus infection in the elderly. Epidemiology, prophylaxis and optimal treatment.

Authors:  J Hayashi; S Kashiwagi
Journal:  Drugs Aging       Date:  1997-10       Impact factor: 3.923

2.  Novel, ligation-dependent PCR assay for detection of hepatitis C in serum.

Authors:  T C Hsuih; Y N Park; C Zaretsky; F Wu; S Tyagi; F R Kramer; R Sperling; D Y Zhang
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

3.  Clinical study of IgA antibody against hepatitis C virus core antigen in patients with type C chronic liver disease.

Authors:  M Tanaka; S Sato; S Fujiyama; S Kawano; Y Taura; H Chikazawa; Y Honda; J Shibata; T Sato
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

4.  Detection of hepatitis C virus RNA: comparison of one-stage polymerase chain reaction (PCR) with nested-set PCR.

Authors:  D R Gretch; J J Wilson; R L Carithers; C dela Rosa; J H Han; L Corey
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

5.  Analysing the sequence diversity of the 5' NC-region of HCV-isolates found in southern Germany.

Authors:  M Da Silva Cardoso; S Epple; K Koerner; B Kubanek
Journal:  Eur J Epidemiol       Date:  1994-10       Impact factor: 8.082

6.  Prevalence and significance of hepatitis C virus (HCV) viremia in HCV antibody-positive subjects from various populations.

Authors:  M François; F Dubois; D Brand; Y Bacq; C Guerois; C Mouchet; J Tichet; A Goudeau; F Barin
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

7.  Peptide immunogen mimicry of putative E1 glycoprotein-specific epitopes in hepatitis C virus.

Authors:  R Ray; A Khanna; L M Lagging; K Meyer; Q L Choo; R Ralston; M Houghton; P R Becherer
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

8.  Genomic structure of the human prototype strain H of hepatitis C virus: comparison with American and Japanese isolates.

Authors:  G Inchauspe; S Zebedee; D H Lee; M Sugitani; M Nasoff; A M Prince
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

9.  The serology of hepatitis C virus (HCV) infection: antibody crossreaction in the hypervariable region 1.

Authors:  M da Silva Cardoso; K Siemoneit; V Nemecek; S Epple; K Koerner; B Kubanek
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

10.  Interaction of immune complexes isolated from hepatitis C virus-infected individuals with human cell lines.

Authors:  Rafael Marino; Leopoldo Deibis; Juan B De Sanctis; Nicolas E Bianco; Felix Toro
Journal:  Med Microbiol Immunol       Date:  2005-01       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.